349 related articles for article (PubMed ID: 22191128)
1. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
2. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
3. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
5. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M; Alvarez RD; Kinney WK; Wilson TO
Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
10. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
11. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
12. Pelvic exenteration for recurrent endometrial cancer.
Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
16. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
17. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
Forner DM; Lampe B
Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
19. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis?
Colibaseanu DT; Mathis KL; Abdelsattar ZM; Larson DW; Haddock MG; Dozois EJ
Dis Colon Rectum; 2013 Jan; 56(1):14-9. PubMed ID: 23222275
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategy for local recurrence after resection of rectal cancer.
Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S
Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
